Our innovation
Our innovation with Hyaluronic Acid
We continue to innovate with this molecule, gradually establishing ourselves in the field of regenerative medicine.
Research and Development
The importance of research: our approach, the most important patents, our clinical trials.
Regenerative Care
New horizons, which are now a reality, to counteract aging or loss of function of certain body tissues.
Fully Integrated Company
This means that we are able to cover the entire product life cycle – from early discovery to manufacturing and marketing.
HYALURONIC ACID
FINISHED PRODUCT
VACCINE PRODUCTION
DELIVERY SYSTEMS
Quality system
Our Quality Management System plays an essential role in ensuring compliance with mandatory and voluntary regulatory requirements.
We undergo periodical inspections by national AIFA, the Italian Ministry of Health) and International (US FDA, Korean Ministry of Food and Drug Safety [KFDA], ANVISA Brazil, Pharmaceutical Inspectorate of the Ministry of Industry and Trade of the Russian Federation) regulatory authorities and auditing by notified bodies.
Our commitment on Investigator Initiated Studies
Fidia is willing to support Investigator-Initiated Studies in countries where this is compatible with applicable local regulations.
Investigator Initiated Studies are studies designed, initiated, conducted and managed under the full responsibility of a non-Fidia investigator in compliance with applicable regulations to ensure the data protection rights, safety and wellbeing of patients. The Investigator is the Sponsor of the study in which Fidia can provide financial or non-financial support.
We strongly believe in supporting Investigator Initiated Studies with the purpose to improve patients’ health and quality of life and better understand the risk/benefit profile of the products, as well as to evaluate new clinical opportunities and unmet medical needs.
Fidia Farmaceutici may provide the Investigator with financial and/or non-financial support such as product supply, material and/or services.
Fidia Farmaceutici has no role in the planning or conduct of the study but supports the Investigators in pursuing their own research interests, which are of scientific merit and promote legitimate research goals.
Investigators are invited to submit their proposal through this request form.
Investigator will be informed about the outcome and should Fidia Farmaceutici be interested in the concept submitted, the investigator will be contacted and invited to submit further details and a final protocol on the Investigator Initiated Study in order to be considered for full approval.